Martin R Wilhelm

Title: Martin R Wilhelm: Innovator in Plasmid Technology

Introduction

Martin R Wilhelm is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of plasmids for protein expression. His work has implications for therapeutic applications, showcasing the intersection of innovation and healthcare.

Latest Patents

Wilhelm holds a patent for "Plasmids, their construction and their use in the manufacture of a recombinant protein." This patent describes plasmids containing synthetic DNA sequences that are designed for the expression of the intermediate protein of the recombinant scu-PA. The plasmids enable expression rates that surpass those achieved by previous methods. They include operons with a regulatable promoter, a Shine-Dalgarno sequence, a start codon, and a synthetic structural gene. The preparation of these plasmids allows for high yields of the intermediate protein, which can be refolded to produce a therapeutically useful plasminogen activator.

Career Highlights

Wilhelm is associated with Gruenenthal GmbH, where he continues to advance his research in plasmid technology. His innovative work has positioned him as a key figure in the biotechnology sector, contributing to the development of effective therapeutic proteins.

Collaborations

Throughout his career, Wilhelm has collaborated with esteemed colleagues such as Regina E Brigelius-Flohe and Wolfgang Hillen. These partnerships have fostered a collaborative environment that enhances research and innovation in the field.

Conclusion

Martin R Wilhelm's contributions to plasmid technology exemplify the vital role of inventors in advancing biotechnology. His patent and ongoing work at Gruenenthal GmbH highlight the importance of innovation in developing therapeutic solutions.